Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6.
Saved in:
| Title: | Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6. |
|---|---|
| Authors: | Chandak S; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK., Gurudas S; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.; Institute of Ophthalmology, University College, London, UK., Pakeer Muhammed R; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK., Keskin A; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK., Thottarath S; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK., Ghanchi F; Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK., Grabowska A; King's College Hospital NHS Foundation Trust, London, UK., Talks SJ; Newcastle Hospitals NHS Foundation Trust, Newcastle, UK., Pearce I; The Royal Liverpool and Broadgreen University Hospitals NHS Foundation Trust, Liverpool, UK., McKibbin M; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Kotagiri A; South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK., Menon G; Frimley Health NHS Foundation Trust, Surrey, UK., Burton BJL; James Paget University Hospitals NHS Foundation Trust, Norfolk, UK., Gale R; York Teaching Hospital NHS Foundation Trust, York, UK., Sivaprasad S; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK. senswathi@aol.com.; Institute of Ophthalmology, University College, London, UK. senswathi@aol.com. |
| Source: | Eye (London, England) [Eye (Lond)] 2025 Aug; Vol. 39 (11), pp. 2194-2203. Date of Electronic Publication: 2025 May 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40355704 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chandak+S%22">Chandak S</searchLink>; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Gurudas+S%22">Gurudas S</searchLink>; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.; Institute of Ophthalmology, University College, London, UK.<br /><searchLink fieldCode="AU" term="%22Pakeer+Muhammed+R%22">Pakeer Muhammed R</searchLink>; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Keskin+A%22">Keskin A</searchLink>; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Thottarath+S%22">Thottarath S</searchLink>; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Ghanchi+F%22">Ghanchi F</searchLink>; Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.<br /><searchLink fieldCode="AU" term="%22Grabowska+A%22">Grabowska A</searchLink>; King's College Hospital NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Talks+SJ%22">Talks SJ</searchLink>; Newcastle Hospitals NHS Foundation Trust, Newcastle, UK.<br /><searchLink fieldCode="AU" term="%22Pearce+I%22">Pearce I</searchLink>; The Royal Liverpool and Broadgreen University Hospitals NHS Foundation Trust, Liverpool, UK.<br /><searchLink fieldCode="AU" term="%22McKibbin+M%22">McKibbin M</searchLink>; Leeds Teaching Hospitals NHS Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Kotagiri+A%22">Kotagiri A</searchLink>; South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.<br /><searchLink fieldCode="AU" term="%22Menon+G%22">Menon G</searchLink>; Frimley Health NHS Foundation Trust, Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Burton+BJL%22">Burton BJL</searchLink>; James Paget University Hospitals NHS Foundation Trust, Norfolk, UK.<br /><searchLink fieldCode="AU" term="%22Gale+R%22">Gale R</searchLink>; York Teaching Hospital NHS Foundation Trust, York, UK.<br /><searchLink fieldCode="AU" term="%22Sivaprasad+S%22">Sivaprasad S</searchLink>; National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK. senswathi@aol.com.; Institute of Ophthalmology, University College, London, UK. senswathi@aol.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228703986%22">Eye (London, England)</searchLink> [Eye (Lond)] 2025 Aug; Vol. 39 (11), pp. 2194-2203. <i>Date of Electronic Publication: </i>2025 May 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8703986 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5454 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220950222X%22">0950222X </searchLink><i>NLM ISO Abbreviation: </i>Eye (Lond) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40355704 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41433-025-03797-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2194 Titles: – TitleFull: Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chandak S – PersonEntity: Name: NameFull: Gurudas S – PersonEntity: Name: NameFull: Pakeer Muhammed R – PersonEntity: Name: NameFull: Keskin A – PersonEntity: Name: NameFull: Thottarath S – PersonEntity: Name: NameFull: Ghanchi F – PersonEntity: Name: NameFull: Grabowska A – PersonEntity: Name: NameFull: Talks SJ – PersonEntity: Name: NameFull: Pearce I – PersonEntity: Name: NameFull: McKibbin M – PersonEntity: Name: NameFull: Kotagiri A – PersonEntity: Name: NameFull: Menon G – PersonEntity: Name: NameFull: Burton BJL – PersonEntity: Name: NameFull: Gale R – PersonEntity: Name: NameFull: Sivaprasad S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-5454 Numbering: – Type: volume Value: 39 – Type: issue Value: 11 Titles: – TitleFull: Eye (London, England) Type: main |
| ResultId | 1 |
